Abreu, M., Cabezas-Sainz, P., Pereira-Veiga, T., Falo, C., Abalo, A., Morilla, I., Curiel, T., Cueva, J., Rodríguez, C., Varela-Pose, V., Lago-Lestón, R., Mondelo, P., Palacios, P., Moreno-Bueno, G., Cano, A., García-Caballero, T., Pujana, M.Á., Sánchez-Piñón, L., Costa, C., López, R., Muinelo-Romay, L. (2020) Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells. Journal of clinical medicine. 9(2)
|
Crozier, M., Tubman, J., Fifield, B.A., Ferraiuolo, R.M., Ritchie, J., Zuccato, K., Mailloux, E., Sinha, I., Hamm, C., Porter, L.A. (2022) Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells. PLoS One. 17:e0274675
|
|
|
Li, J., Lai, Y., Ma, J., Liu, Y., Bi, J., Zhang, L., Chen, L., Yao, C., Lv, W., Chang, G., Wang, S., Ouyang, M., Wang, W. (2017) miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. BMC cancer. 17:745
|
Pan, H., Peng, Z., Lin, J., Ren, X., Zhang, G., Cui, Y. (2018) Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4. Cancer science. 109(12):3794-3804
|
Saraiva, S.M., Gutiérrez-Lovera, C., Martínez-Val, J., Lores, S., Bouzo, B.L., Díez-Villares, S., Alijas, S., Pensado-López, A., Vázquez-Ríos, A.J., Sánchez, L., de la Fuente, M. (2021) Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model. Scientific Reports. 11:9873
|
Truong, H.H., Xiong, J., Ghotra, V.P., Nirmala, E., Haazen, L., Le Dévédec, S.E., Balcioğlu, H.E., He, S., Snaar-Jagalska, B.E., Vreugdenhil, E., Meerman, J.H., van de Water, B., Danen, E.H. (2014) β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.. Science signaling. 7(312):ra15
|
Tulotta, C., Stefanescu, C., Beletkaia, E., Bussmann, J., Tarbashevich, K., Schmidt, T., Snaar-Jagalska, B.E. (2016) Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Disease models & mechanisms. 9(2):141-53
|
Winter, M., Meignan, S., Völkel, P., Angrand, P.O., Chopin, V., Bidan, N., Toillon, R.A., Adriaenssens, E., Lagadec, C., Le Bourhis, X. (2021) Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment. Cells. 10(6):
|
Zhao, X., Li, L., Yu, G., Zhang, S., Li, Y., Wu, Q., Huang, X., Mei, W. (2018) Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo. Computational and structural biotechnology journal. 17:21-30
|
Zheng, M.W., Zhang, C.H., Chen, K., Huang, M., Li, Y.P., Lin, W.T., Zhang, R.J., Zhong, L., Xiang, R., Li, L.L., Liu, X.Y., Wei, Y.Q., Yang, S.Y. (2016) Preclinical evaluation of a novel orally available SRC/Raf/VEGFR2 inhibitor, SKLB646, in the treatment of triple negative breast cancer. Molecular cancer therapeutics. 15(3):366-78
|
